ATE430938T1 - Verfahren zur vorhersage des zustands der magenschleimhaut - Google Patents

Verfahren zur vorhersage des zustands der magenschleimhaut

Info

Publication number
ATE430938T1
ATE430938T1 AT05717315T AT05717315T ATE430938T1 AT E430938 T1 ATE430938 T1 AT E430938T1 AT 05717315 T AT05717315 T AT 05717315T AT 05717315 T AT05717315 T AT 05717315T AT E430938 T1 ATE430938 T1 AT E430938T1
Authority
AT
Austria
Prior art keywords
gastric mucosa
data
subject
predicting
condition
Prior art date
Application number
AT05717315T
Other languages
English (en)
Inventor
Seppo Sarna
Tapani Tiusanen
Osmo Suovaniemi
Original Assignee
Biohit Oyj
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biohit Oyj filed Critical Biohit Oyj
Application granted granted Critical
Publication of ATE430938T1 publication Critical patent/ATE430938T1/de

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/575—Hormones
    • G01N2333/595—Gastrins; Cholecystokinins [CCK]
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)
    • G01N2333/96475—Aspartic endopeptidases (3.4.23) with definite EC number
    • G01N2333/96477—Pepsin (3.4.23.1; 3.4.23.2; 3.4.23.3)
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/06—Gastro-intestinal diseases
    • G01N2800/062—Gastritis or peptic ulcer disease

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Saccharide Compounds (AREA)
  • Compounds Of Unknown Constitution (AREA)
AT05717315T 2004-03-05 2005-03-03 Verfahren zur vorhersage des zustands der magenschleimhaut ATE430938T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FI20040359A FI119572B (fi) 2004-03-05 2004-03-05 Menetelmä vatsan limakalvon tilan ennustamiseksi
PCT/FI2005/050061 WO2005085871A1 (en) 2004-03-05 2005-03-03 A method for predicting the state of the gastric mucosa

Publications (1)

Publication Number Publication Date
ATE430938T1 true ATE430938T1 (de) 2009-05-15

Family

ID=32039385

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05717315T ATE430938T1 (de) 2004-03-05 2005-03-03 Verfahren zur vorhersage des zustands der magenschleimhaut

Country Status (10)

Country Link
US (1) US20080162101A1 (de)
EP (1) EP1725876B1 (de)
JP (1) JP4814212B2 (de)
CN (1) CN1950704A (de)
AT (1) ATE430938T1 (de)
DE (1) DE602005014345D1 (de)
ES (1) ES2325170T3 (de)
FI (1) FI119572B (de)
PL (1) PL1725876T3 (de)
WO (1) WO2005085871A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2009053537A1 (en) * 2007-10-26 2009-04-30 Biohit Oyj Methods and products for diagnosing autoimmune diseases and gastric cancer linked with atrophic gastritis
WO2011161301A1 (en) * 2010-06-24 2011-12-29 Valtion Teknillinen Tutkimuskeskus State inference in a heterogeneous system
AU2012253422B2 (en) 2011-05-10 2015-08-13 Société des Produits Nestlé S.A. Methods of disease activity profiling for personalized therapy management
EP3612843A1 (de) 2017-05-31 2020-02-26 Prometheus Biosciences, Inc. Verfahren zur beurteilung der schleimhautheilung bei patienten mit morbus crohn
CN112002414B (zh) * 2020-08-23 2024-01-26 吾征智能技术(北京)有限公司 一种基于胃液认知胃病的系统、设备、存储介质
CN113466471B (zh) * 2021-09-06 2021-11-26 中国农业科学院农产品加工研究所 胃粘膜损伤相关生物标志物、筛选方法及用途

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0746111B2 (ja) * 1988-03-18 1995-05-17 株式会社日立製作所 試料分析方法及びこれを用いた自動分析装置
US6861510B1 (en) * 1989-01-24 2005-03-01 Aphton Corporation Immunogenic compositions against gastrin peptides
FI97304C (fi) * 1994-11-16 1996-11-25 Locus Genex Oy Menetelmä mahasyövän riskin seulonnaksi
JP2949474B2 (ja) * 1995-08-28 1999-09-13 隆久 古田 ペプシノーゲンｉ／ｉｉ比の変化率を基礎としたヘリコバクター・ピロリ除菌判定方法
JP2000270897A (ja) * 1999-03-23 2000-10-03 Mitsubishi Kagaku Bio-Clinical Laboratories Inc トランスフォーミング増殖因子β１の遺伝子多型による骨粗鬆症危険因子の検出法
FI118653B (fi) * 1999-04-30 2008-01-31 Biohit Oyj Menetelmä peptisen haavan riskin määrittämiseksi
CA2404852A1 (en) * 2000-04-10 2001-10-18 Timothy C. Wang Diagnosis and treatment of gastrointestinal disease
FI20010019L (fi) * 2001-01-05 2002-07-06 Biohit Oyj Menetelmä atrofisen diagnostisoimiseksi
FI20011908L (fi) * 2001-09-28 2003-03-29 Biohit Oyj Menetelmä vatsasyövän osoittamiseksi
SE0200974D0 (sv) * 2002-03-27 2002-03-27 Phagen Ab Screening method for gastritis
FI119571B (fi) * 2002-09-06 2008-12-31 Biohit Oyj Menetelmä esofagiitin tai Barrettin ruokatorven riskin osoittamiseksi yksilöllä
US6950544B2 (en) * 2003-02-14 2005-09-27 Virtualscopics, Llc Automated measurement of anatomical structures in medical imaging

Also Published As

Publication number Publication date
DE602005014345D1 (de) 2009-06-18
FI20040359L (fi) 2005-09-06
ES2325170T3 (es) 2009-08-27
EP1725876A1 (de) 2006-11-29
CN1950704A (zh) 2007-04-18
FI20040359A0 (fi) 2004-03-05
FI119572B (fi) 2008-12-31
EP1725876B1 (de) 2009-05-06
JP4814212B2 (ja) 2011-11-16
US20080162101A1 (en) 2008-07-03
PL1725876T3 (pl) 2009-10-30
WO2005085871A1 (en) 2005-09-15
JP2007526470A (ja) 2007-09-13

Similar Documents

Publication Publication Date Title
FI20010019A7 (fi) Menetelmä atrofisen gastriitin diagnostisoimiseksi
DE602004012974D1 (de) Abtastungverfahren und -vorrichtung zur abtastung von korrosion und oberflächenfehlern
NO20070611L (no) Resekvensering av patogene mikroarray.
WO2006126008A3 (en) Improved immunoassay methods
DE602005013750D1 (de) Stoffwechselüberwachung, verfahren und gerät zur aerson
ATE536553T1 (de) Verfahren zum nachweis grösserer ungünstiger kardiovaskulärer und zerebrovaskulärer ereignisse
WO2010013138A3 (en) Methods and compositions for detection of a pathogen, disease, medical condition, or biomarker thereof
ATE370414T1 (de) Verwendung von nicotinamide n-methyltransferase zur diagnose von kolorektalem krebs
CA2701341A1 (en) Method of assessing colorectal cancer from a stool sample by use of the marker combination calprotectin and hemoglobin/haptoglobin complex
RU2020127440A (ru) Способы, применения и наборы для диагностики заболеваний периодонта
WO2020247952A2 (en) Systems comprising substrates and methods of using the same for detection of pancreatic cancers
DE602006006855D1 (de) Morbus alzheimer-spezifische veränderungen des erkheimer-spezifische molekulare biomarker (adsmb)
ATE430938T1 (de) Verfahren zur vorhersage des zustands der magenschleimhaut
EA200500449A1 (ru) Способ выявления риска развития у субъекта заболевания, связанного с кислотой
ATE331044T1 (de) Verfahren zur integrierten integritätsbewertung und analyse von nukleinsäuren
ATE528647T1 (de) Verfahren zur untersuchung von protein-protein- interaktionen
RU2020127365A (ru) Способы, применения и комплекты для диагностики пародонтита
CN112080550B (zh) 一种检测基质金属蛋白酶的生物传感器及应用
DE602004001994D1 (de) Verwendung des proteins masp als marker für kolorektale karzinome
ATE455297T1 (de) Mikrosensor zur bestimmung von d-aminosäuren
DE602005013430D1 (de) Verwendung von asc als marker für kolorektalkarzinome
DE602005010548D1 (de) Verbessertes verfahren zur diagnose des akuten koronarsyndroms
WO2007012937B1 (en) Method for diagnosis of glioma distinguishing between progressive and denovo types
Magoga et al. CAN A NOVEL BIOMARKER ASSESS PROGNOSIS AT THE TIME OF ADMISSION OF THE COLIC HORSE?
US20190324018A1 (en) Saliva reagent strip for detecting concentration of pepsin or pepsinogen

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1725876

Country of ref document: EP

REN Ceased due to non-payment of the annual fee